TTK and Alzheimer disease: In the present study, the AD-Con group showed reduced phosphorylated cAMP responding element-binding protein (pCREB), pAkt, and pGSK-3β phosphorylation in the hippocampus, and AD-TTK inhibited their reduction (Figure 4D,D-1).